T2 Biosystems (TTOO) Competitors

$0.0007 0.00 (-76.67%)

As of 03:50 PM Eastern

TTOO vs. VRAYQ, WOK, AFIB, UTRS, and MOTS

Should you be buying T2 Biosystems stock or one of its competitors? The main competitors of T2 Biosystems include ViewRay (VRAYQ), WORK Medical Technology Group (WOK), Acutus Medical (AFIB), Minerva Surgical (UTRS), and Motus GI (MOTS). These companies are all part of the "medical equipment" industry.

How does T2 Biosystems compare to ViewRay?

ViewRay (NASDAQ:VRAYQ) and T2 Biosystems (NASDAQ:TTOO) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their valuation, profitability, earnings, media sentiment, risk, analyst recommendations, institutional ownership and dividends.

: T2 Biosystems has lower revenue, but higher earnings than ViewRay. T2 Biosystems is trading at a lower price-to-earnings ratio than ViewRay, indicating that it is currently the more affordable of the two stocks.
Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
ViewRay $102.21M 0.00 -$107.33M -$0.31 N/A
T2 Biosystems $7.68M 0.00 -$50.08M -$3.89 N/A
: 15.5% of ViewRay shares are held by institutional investors. Comparatively, 23.2% of T2 Biosystems shares are held by institutional investors. 2.5% of ViewRay shares are held by insiders. Comparatively, 0.0% of T2 Biosystems shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.
: ViewRay has a beta of 0.9, meaning that its share price is 10% less volatile than the S&P 500. Comparatively, T2 Biosystems has a beta of 8.16, meaning that its share price is 716% more volatile than the S&P 500.
: ViewRay has a net margin of 0.00% compared to T2 Biosystems' net margin of -563.16%.
Company Net Margins Return on Equity Return on Assets
ViewRay N/A N/A N/A
T2 Biosystems -563.16% N/A -174.06%
: In the previous week, ViewRay's average media sentiment score of 0.00 equaled T2 Biosystems'average media sentiment score.
Company Overall Sentiment
ViewRay Neutral
T2 Biosystems Neutral

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
ViewRay	$102.21M	0.00	-$107.33M	-$0.31	N/A
T2 Biosystems	$7.68M	0.00	-$50.08M	-$3.89	N/A

Company	Net Margins	Return on Equity	Return on Assets
ViewRay	N/A	N/A	N/A
T2 Biosystems	-563.16%	N/A	-174.06%

Company	Overall Sentiment
ViewRay	Neutral
T2 Biosystems	Neutral

Summary

ViewRay beats T2 Biosystems on 5 of the 9 factors compared between the two stocks.

How does T2 Biosystems compare to WORK Medical Technology Group?

WORK Medical Technology Group (NASDAQ:WOK) and T2 Biosystems (NASDAQ:TTOO) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their profitability, dividends, earnings, risk, media sentiment, valuation, analyst recommendations and institutional ownership.

: WORK Medical Technology Group has a net margin of 0.00% compared to T2 Biosystems' net margin of -563.16%.
Company Net Margins Return on Equity Return on Assets
WORK Medical Technology Group N/A N/A N/A
T2 Biosystems -563.16% N/A -174.06%
: In the previous week, WORK Medical Technology Group had 2 more articles in the media than T2 Biosystems. MarketBeat recorded 2 mentions for WORK Medical Technology Group and 0 mentions for T2 Biosystems. WORK Medical Technology Group's average media sentiment score of 1.00 beat T2 Biosystems' score of 0.00 indicating that WORK Medical Technology Group is being referred to more favorably in the media.
Company Overall Sentiment
WORK Medical Technology Group Positive
T2 Biosystems Neutral
: WORK Medical Technology Group has higher revenue and earnings than T2 Biosystems.
Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
WORK Medical Technology Group $9.81M 0.00 -$1.07M N/A N/A
T2 Biosystems $7.68M 0.00 -$50.08M -$3.89 N/A
: Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
WORK Medical Technology Group
1 Sell rating(s)
0 Hold rating(s)

0 Buy rating(s)

0 Strong Buy rating(s)
1.00
T2 Biosystems
0 Sell rating(s)

0 Hold rating(s)

0 Buy rating(s)

0 Strong Buy rating(s)
0.00
: WORK Medical Technology Group has a beta of 2.37, meaning that its stock price is 137% more volatile than the S&P 500. Comparatively, T2 Biosystems has a beta of 8.16, meaning that its stock price is 716% more volatile than the S&P 500.
: 23.2% of T2 Biosystems shares are held by institutional investors. 0.0% of T2 Biosystems shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Company	Net Margins	Return on Equity	Return on Assets
WORK Medical Technology Group	N/A	N/A	N/A
T2 Biosystems	-563.16%	N/A	-174.06%

Company	Overall Sentiment
WORK Medical Technology Group	Positive
T2 Biosystems	Neutral

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
WORK Medical Technology Group	$9.81M	0.00	-$1.07M	N/A	N/A
T2 Biosystems	$7.68M	0.00	-$50.08M	-$3.89	N/A

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
WORK Medical Technology Group	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
T2 Biosystems	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

Summary

WORK Medical Technology Group beats T2 Biosystems on 7 of the 11 factors compared between the two stocks.

How does T2 Biosystems compare to Acutus Medical?

Acutus Medical (NASDAQ:AFIB) and T2 Biosystems (NASDAQ:TTOO) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their profitability, dividends, earnings, risk, media sentiment, valuation, analyst recommendations and institutional ownership.

: Acutus Medical has a net margin of -272.74% compared to T2 Biosystems' net margin of -563.16%. T2 Biosystems' return on equity of 0.00% beat Acutus Medical's return on equity.
Company Net Margins Return on Equity Return on Assets
Acutus Medical -272.74% -311.64% -11.57%
T2 Biosystems -563.16% N/A -174.06%
: In the previous week, Acutus Medical's average media sentiment score of 0.00 equaled T2 Biosystems'average media sentiment score.
Company Overall Sentiment
Acutus Medical Neutral
T2 Biosystems Neutral
: T2 Biosystems has higher revenue and earnings than Acutus Medical. Acutus Medical is trading at a lower price-to-earnings ratio than T2 Biosystems, indicating that it is currently the more affordable of the two stocks.
Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Acutus Medical $7.16M 0.00 -$81.66M -$0.11 N/A
T2 Biosystems $7.68M 0.00 -$50.08M -$3.89 N/A
: Acutus Medical has a beta of 6.03, indicating that its share price is 503% more volatile than the S&P 500. Comparatively, T2 Biosystems has a beta of 8.16, indicating that its share price is 716% more volatile than the S&P 500.
: 56.9% of Acutus Medical shares are held by institutional investors. Comparatively, 23.2% of T2 Biosystems shares are held by institutional investors. 5.2% of Acutus Medical shares are held by insiders. Comparatively, 0.0% of T2 Biosystems shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Company	Net Margins	Return on Equity	Return on Assets
Acutus Medical	-272.74%	-311.64%	-11.57%
T2 Biosystems	-563.16%	N/A	-174.06%

Company	Overall Sentiment
Acutus Medical	Neutral
T2 Biosystems	Neutral

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Acutus Medical	$7.16M	0.00	-$81.66M	-$0.11	N/A
T2 Biosystems	$7.68M	0.00	-$50.08M	-$3.89	N/A

Summary

T2 Biosystems beats Acutus Medical on 6 of the 11 factors compared between the two stocks.

How does T2 Biosystems compare to Minerva Surgical?

T2 Biosystems (NASDAQ:TTOO) and Minerva Surgical (NASDAQ:UTRS) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their valuation, risk, profitability, institutional ownership, media sentiment, earnings, dividends and analyst recommendations.

: 23.2% of T2 Biosystems shares are owned by institutional investors. 0.0% of T2 Biosystems shares are owned by company insiders. Comparatively, 8.5% of Minerva Surgical shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.
: In the previous week, Minerva Surgical had 1 more articles in the media than T2 Biosystems. MarketBeat recorded 1 mentions for Minerva Surgical and 0 mentions for T2 Biosystems. T2 Biosystems' average media sentiment score of 0.00 equaled Minerva Surgical'saverage media sentiment score.
Company Overall Sentiment
T2 Biosystems Neutral
Minerva Surgical Neutral
: Minerva Surgical has a net margin of 0.00% compared to T2 Biosystems' net margin of -563.16%.
Company Net Margins Return on Equity Return on Assets
T2 Biosystems -563.16% N/A -174.06%
Minerva Surgical N/A N/A N/A
: T2 Biosystems has a beta of 8.16, suggesting that its stock price is 716% more volatile than the S&P 500. Comparatively, Minerva Surgical has a beta of 2.92, suggesting that its stock price is 192% more volatile than the S&P 500.
: Minerva Surgical has higher revenue and earnings than T2 Biosystems. T2 Biosystems is trading at a lower price-to-earnings ratio than Minerva Surgical, indicating that it is currently the more affordable of the two stocks.
Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
T2 Biosystems $7.68M 0.00 -$50.08M -$3.89 N/A
Minerva Surgical $51.69M 0.00 -$34.11M -$4.21 N/A

Company	Overall Sentiment
T2 Biosystems	Neutral
Minerva Surgical	Neutral

Company	Net Margins	Return on Equity	Return on Assets
T2 Biosystems	-563.16%	N/A	-174.06%
Minerva Surgical	N/A	N/A	N/A

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
T2 Biosystems	$7.68M	0.00	-$50.08M	-$3.89	N/A
Minerva Surgical	$51.69M	0.00	-$34.11M	-$4.21	N/A

Summary

Minerva Surgical beats T2 Biosystems on 7 of the 10 factors compared between the two stocks.

How does T2 Biosystems compare to Motus GI?

T2 Biosystems (NASDAQ:TTOO) and Motus GI (NASDAQ:MOTS) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their valuation, risk, profitability, institutional ownership, media sentiment, earnings, dividends and analyst recommendations.

: In the previous week, T2 Biosystems' average media sentiment score of 0.00 equaled Motus GI'saverage media sentiment score.
Company Overall Sentiment
T2 Biosystems Neutral
Motus GI Neutral
: Motus GI has a net margin of 0.00% compared to T2 Biosystems' net margin of -563.16%.
Company Net Margins Return on Equity Return on Assets
T2 Biosystems -563.16% N/A -174.06%
Motus GI N/A N/A N/A
: Motus GI has lower revenue, but higher earnings than T2 Biosystems. T2 Biosystems is trading at a lower price-to-earnings ratio than Motus GI, indicating that it is currently the more affordable of the two stocks.
Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
T2 Biosystems $7.68M 0.00 -$50.08M -$3.89 N/A
Motus GI $319K 0.00 -$12.87M -$14.69 N/A
: 23.2% of T2 Biosystems shares are owned by institutional investors. Comparatively, 20.1% of Motus GI shares are owned by institutional investors. 0.0% of T2 Biosystems shares are owned by company insiders. Comparatively, 0.3% of Motus GI shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.
: T2 Biosystems has a beta of 8.16, suggesting that its stock price is 716% more volatile than the S&P 500. Comparatively, Motus GI has a beta of 0.87, suggesting that its stock price is 13% less volatile than the S&P 500.

Company	Overall Sentiment
T2 Biosystems	Neutral
Motus GI	Neutral

Company	Net Margins	Return on Equity	Return on Assets
T2 Biosystems	-563.16%	N/A	-174.06%
Motus GI	N/A	N/A	N/A

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
T2 Biosystems	$7.68M	0.00	-$50.08M	-$3.89	N/A
Motus GI	$319K	0.00	-$12.87M	-$14.69	N/A

Summary

T2 Biosystems and Motus GI tied by winning 5 of the 10 factors compared between the two stocks.

Get T2 Biosystems News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding TTOO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

TTOO vs. The Competition

Export

Metric	T2 Biosystems	Surgical & medical instruments Industry	Medical Sector	NASDAQ Exchange
Market Cap	$15K	$46.11M	$6.25B	$11.87B
Dividend Yield	N/A	1.08%	2.73%	5.21%
P/E Ratio	0.00	18.58	29.04	28.48
Price / Sales	0.00	30.72	476.48	60.89
Price / Cash	N/A	18.88	27.62	36.52
Price / Book	0.00	14.27	9.67	6.67
Net Income	-$50.08M	-$20.10M	$3.55B	$332.64M
7 Day Performance	N/A	-1.39%	1.70%	2.01%
1 Month Performance	N/A	-1.61%	5.62%	9.19%
1 Year Performance	N/A	10.93%	34.42%	39.59%

T2 Biosystems Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
TTOO T2 Biosystems	N/A	$0.00 -76.7%	N/A	N/A	$15K	$7.68M	N/A	180	Gap Up
VRAYQ ViewRay	N/A	N/A	N/A	N/A	$18K	$102.21M	N/A	300
WOK WORK Medical Technology Group	N/A	$1.20 +0.0%	N/A	N/A	$12K	$9.85M	N/A	226
AFIB Acutus Medical	N/A	$0.00 -50.0%	N/A	N/A	$3K	$7.16M	N/A	340	Upcoming Earnings High Trading Volume
UTRS Minerva Surgical	N/A	N/A	N/A	N/A	$1K	$51.69M	N/A	160	News Coverage Upcoming Earnings

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:TTOO) was last updated on 5/5/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

T2 Biosystems (TTOO) Competitors

TTOO vs. VRAYQ, WOK, AFIB, UTRS, and MOTS

How does T2 Biosystems compare to ViewRay?

Summary

How does T2 Biosystems compare to WORK Medical Technology Group?

Summary

How does T2 Biosystems compare to Acutus Medical?

Summary

How does T2 Biosystems compare to Minerva Surgical?

Summary

How does T2 Biosystems compare to Motus GI?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

TTOO vs. The Competition

T2 Biosystems Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

T2 Biosystems (TTOO) Competitors

TTOO vs. VRAYQ, WOK, AFIB, UTRS, and MOTS

How does T2 Biosystems compare to ViewRay?

Summary

How does T2 Biosystems compare to WORK Medical Technology Group?

Summary

How does T2 Biosystems compare to Acutus Medical?

Summary

How does T2 Biosystems compare to Minerva Surgical?

Summary

How does T2 Biosystems compare to Motus GI?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

TTOO vs. The Competition

T2 Biosystems Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools